Abstract
Aim: HLA-B*27 is a risk marker for ankylosing spondylitis. We compared three methods of HLA-B*27 detection in a New South Wales (NSW) population – flow cytometry, rs4349859 single nucleotide polymorphism (SNP) assay, and allele-specific real-time polymerase chain reaction (RT-PCR) analysis of exons 2 and 3.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
